{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-043338","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.064418+00:00","generated_at":"2026-05-25T20:17:53.717181+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Scilex sells 4% royalty on Gloperba/Elyxyb to defer Tranche B amortization to 2026","bullets":["Sold 4% of aggregate net sales of Gloperba and Elyxyb to Oramed, Murchinson, and 3i; consideration is deferral of First Amortization Payment on Tranche B Notes to Oct 8, 2026.","Entered Security Agreement granting first-priority liens on royalty collateral; Note Agent's lien subordinated to second priority.","Licensed exclusive worldwide ex-US rights to Gloperba to RoyaltyVest Ltd on 50/50 net revenue split.","Amended ZTlido Royalty Agreement to allow asset sale without consent if all Debt Instrument obligations are paid in full.","Transaction closed Feb 28, 2025; grants Royalty and Exclusive Rights under January 2, 2025 Tranche B Consents."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-043338","json":"https://secwatch.observer/filing/0001193125-25-043338.json","markdown":"https://secwatch.observer/filing/0001193125-25-043338.md","text":"https://secwatch.observer/filing/0001193125-25-043338.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525043338/0001193125-25-043338-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525043338/d864577d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T20:17:53.717181+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}